课题基金 / 基金详情

F1Fo-ATP合酶δ亚基在白念珠菌致死性感染中的作用及其机制研究

批准号:
81971913
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
张宏
依托单位:
学科分类:
病原真菌与感染
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
张宏

项目摘要

结项摘要

项目成果

张宏的其他基金

相似基金

相关文献

中文摘要
白念珠菌是重要的致死性真菌,其复杂的致病因子主要靠ATP依赖Ras1-cAMP-PKA通路(“通路”)调控。线粒体ATP合成的终端酶是F1Fo-ATP合酶,其δ亚基功能未知。我们发现:δ亚基缺失后,并未影响细胞内ATP水平,却无法造成小鼠致死;Ras1活性、Cyr1显著抑制;Cdc19与δ亚基互作,生信分析Cdc19-Cyr1-Ras1互作;Cdc19别构激活剂FBP明显降低。据此我们提出,δ亚基并不影响ATP合成、却通过FBP/和Cdc19调控“通路”影响致死性感染。本项目拟以体内外实验确认δ亚基是白念珠菌致死性感染的关键,再以代谢组学、生化手段证明δ亚基不影响各环节ATP合成,以蛋白互作、代谢物蛋白互作等证明δ亚基通过FBP/和Cdc19调控“通路”,以SBVS寻找靶向小分子化合物。项目将从F1Fo-ATP合酶δ亚基这一新视角,揭示白念珠菌致死性感染的关键,为新靶点确认提供扎实证据。
英文摘要
Candida albicans is an important clinical pathogenic fungus causing life-threatening systemic infections, with the multiple pathogenic traits that are mainly regulated by the ATP-dependent Ras1-cAMP-PKA pathway. F1Fo-ATP synthase is the terminal enzyme responsible for mitochondrial ATP synthesis, with the function of the δ subunit remaining enigmatic. Our previous studies have demonstrated that: (i) The absence of the δ subunit in Candida albicans fails to lead to a lethal infection in mice disseminated models, without affecting ATP synthesis; (ii) The activity of Ras1 is significantly suppressed after the deletion of δ subunit, as was the expression level of CYR1; (iii) The evidences for the interaction of the δ subunit with Cdc19 are presented, and bioinformatics analysis indicates a potentially direct interaction between Cdc19-Cyr1-Ras1; (iv) The fructose 1,6-bisphospate (FBP), an allosteric activator of Cdc19, is also significantly reduced. Based on these, we propose that the δ subunit regulates this pathway through FBP/and Cdc19 to lead to a lethal infection rather than affecting ATP synthesis. This project intends to confirm the critical role of δ subunit in leading lethal infection in mice model though in vivo and in vitro studies. Moreover, the metabolomics and biochemical methods are performed to prove that δ subunit does not affect the ATP synthesis in all aspects. Then, protein-protein interactions together with the protein-metabolite interactions will be investigated to better reveal that δ subunit is most likely to regulate this pathway via FBP/and Cdc19. Last, the structure based virtual screening (SBVS) study is to present to identify a novel small molecule compound targeting the δ subunit. The present project will elucidate the key actor of the F1Fo-ATP synthase δ subunit of Candida albicans from a new perspective, and provide solid evidence for new antifungal drug target.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI: 10.1080/21505594.2023.2190645
发表时间: 2023-12
期刊: VIRULENCE
影响因子: 5.2
作者: [Li, Shuixiu, Liu, Yuting, Weng, Luobei, Zhao, Yajing, Zhang, Yishan, Zhang, Zhanpeng, Yang, Yang, Chen, Qiaoxin, Liu, Xiaocong, Zhang, Hong]
通讯作者: Zhang, Hong
The δ subunit of F(1)F(o)-ATP synthase is required for pathogenicity of Candida albicans.
F1Fo-ATP 合酶的 δ 亚基是白色念珠菌致病性所必需的
DOI: 10.1038/s41467-021-26313-9
发表时间: 2021-10-15
期刊: Nature communications
影响因子: 16.6
作者: [Li S, Zhao Y, Zhang Y, Zhang Y, Zhang Z, Tang C, Weng L, Chen X, Zhang G, Zhang H]
通讯作者: Zhang H
Deletion of the ATP2 Gene in Candida albicans Blocks Its Escape From Macrophage Clearance.
白色念珠菌中 ATP2 基因的缺失阻止其逃避巨噬细胞清除
DOI: 10.3389/fcimb.2021.643121
发表时间: 2021
期刊: Frontiers in cellular and infection microbiology
影响因子: 5.7
作者: [Zhang Y, Tang C, Zhang Z, Li S, Zhao Y, Weng L, Zhang H]
通讯作者: Zhang H
The fungal-specific subunit i/j of F1FO-ATP synthase stimulates the pathogenicity of Candida albicans independent of oxidative phosphorylation
F1FO-ATP 合酶的真菌特异性亚基 i/j 刺激白色念珠菌的致病性,与氧化磷酸化无关
DOI: 10.1093/mmy/myaa094
发表时间: 2020
期刊: Med Mycol
影响因子: --
作者: [Yajing Zhao, Yan Lyu, Yanli Zhang, Shuixiu Li, Yishan Zhang, Yuting Liu, Chuanyan Tang, Zhanpeng Zhang, Dongmei Li, Hong Zhang]
通讯作者: Hong Zhang
6
    白念珠菌F1Fo-ATP合酶中创新药靶的识别与确认研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      张宏
    • 依托单位:
    白念珠菌对唑类耐药和汉防己甲素逆转耐药过程中线粒体氧化磷酸化的主要机制
    • 批准号:
      81471995
    • 项目类别:
      面上项目
    • 资助金额:
      62.0万元
    • 批准年份:
      2014
    • 负责人:
      张宏
    • 依托单位:
    ADH1参与白念珠菌对唑类药物耐药及汉防己甲素增效过程中外排泵相关的主要机制
    • 批准号:
      81171542
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2011
    • 负责人:
      张宏
    • 依托单位:
    汉防己甲素对唑类药物抗白念珠菌活性的增效机制
    • 批准号:
      30972660
    • 项目类别:
      面上项目
    • 资助金额:
      28.0万元
    • 批准年份:
      2009
    • 负责人:
      张宏
    • 依托单位:
    国内基金
    海外基金